| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-AK8 (1-200) is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
| Purification: |
Affinity purification |
| Dilution Range: |
WB 1:500-1:2000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
AK8 |
| Gene ID: |
158067 |
| Uniprot ID: |
KAD8_HUMAN |
| Immunogen Region: |
1-200 |
| Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-200 of human AK8 (NP_689785.1). |
| Immunogen Sequence: |
MDATIAPHRIPPEMPQYGEE NHIFELMQNMLEQLLIHQPE DPIPFMIQHLHRDNDNVPRI VILGPPASGKTTIAMWLCKH LNSSLLTLENLILNEFSYTA TEARRLYLQRKTVPSALLVQ LIQERLAEEDCIKQGWILDG IPETREQALRIQTLGITPRH VIVLSAPDTVLIERNLGKRI DPQTGEIYHTTFDWPPESEI |
| Tissue Specificity | Expressed in respiratory cells (at protein level). |
| Function | Nucleoside monophosphate (NMP) kinase that catalyzes the reversible transfer of the terminal phosphate group between nucleoside triphosphates and monophosphates. Has highest activity toward AMP, and weaker activity toward dAMP, CMP and dCMP. Also displays broad nucleoside diphosphate kinase activity. |
| Protein Name | Adenylate Kinase 8Ak 8Atp-Amp Transphosphorylase 8 |
| Database Links | Reactome: R-HSA-499943 |
| Cellular Localisation | CytoplasmCytosolCytoskeletonCilium AxonemeLocated In The Proximal Region Of Respiratory Cilia |
| Alternative Antibody Names | Anti-Adenylate Kinase 8 antibodyAnti-Ak 8 antibodyAnti-Atp-Amp Transphosphorylase 8 antibodyAnti-AK8 antibodyAnti-C9orf98 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
